eBook Series: Innovation Updates and Strategies - - BioPharm International

ADVERTISEMENT

eBook Series: Innovation Updates and Strategies


Biopharmaceutical Innovation Updates and Strategies

By definition, innovation refers to the introduction of something new or different, such as a product, method, or process. In practice, innovation has come to mean a business strategy to find a niche, adapt to changing markets, restructure an organization, maximize an organization’s strengths, or simply stay competitive.

In this “innovation” context, the editors of BioPharm International are pleased to introduce our first eBook, Biopharmaceutical Innovation Updates and Strategies. In this special publication, the editors take a look at the business side of biopharmaceuticals—strategies, practices, and opportunities to fund R&D, protect patents, establish outsourcing partnerships, and manage organizational change.

This digital publication offers added functionality versus a print magazine. You will find embedded videos, podcasts, and links that connect you to additional information and resources. We hope this eBook provides a picture of how innovation—however it is defined—is shaping the biopharmaceutical industry.


--The editors of BioPharm International

View BioPharm International's Biopharmaceutical Innovation Updates and Strategies eBook


Recovering Patent Life with Patent Term Extension Patent Term Extension
Recovering Patent Life with Patent Term Extension
The little-known exception to the patent term extension law is potentially valuable but easy to miss.
Michael T. Siekman and Charles T. Steenburg, Wolf, Greenfield & Sacks, PC

Crowdfunding Biopharmaceutical Innovation

Financing Innovation
Crowdfunding Biopharmaceutical Innovation
Caution should be taken when planning to crowdfund a biopharmaceutical startup.
Seth Mailhot, Paul Jones, and Cameron Field, Michael Best & Friedrich LLP


Restructuring for Biopharmaceutical Success

Profile: Merck Serono
Restructuring for Biopharmaceutical Success
Merck Serono fuels innovation with an integrated research, development, and manufacturing program and seed funding for startups. (Includes audio interview)
Rita Peters, Editorial Director


Creating Better Medicines through Better Conjugation

Profile: Ambrx
Creating Better Medicines through Better Conjugation
Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnershipsto bring drugs with enhanced stability and bioactivity to market.
Cynthia A. Challener, PhD, Contributing Editor


Leveraging Development Strengths Drives Therapies to Market

Profile: NPS Pharmaceuticals
Leveraging Development Strengths Drives Therapies to Market
Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Cynthia A. Challener, PhD, Contributing Editor


Strategic Outsourcing in Clinical Development

Strategic Outsourcing
Strategic Outsourcing in Clinical Development
Partnering with CDMOs can help bridge the innovation gap.
Paul Nelles, Vetter Development Service



Driving Innovation in Biopharmaceuticals

Managing Innovation
Driving Innovation in Biopharmaceuticals
The biopharmaceutical industry must consider new ways to manage innovation, including how product data are handled.
Scott Gibbard, Kalypso



 

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here